Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations
Author(s) -
Krista F. Huybrechts,
Gabriella Bröms,
Lotte Brix Christensen,
Kristjana Einarsdóttir,
Anders Engeland,
Kari Furu,
Mika Gissler,
Sonia Hernández–Dı́az,
Pär Karlsson,
Øystein Karlstad,
Helle Kieler,
AnnaMaria LahesmaaKorpinen,
Helen Mogun,
Mette Nørgaard,
Johan Reutfors,
Henrik Toft Sørensen,
Helga Zoëga,
Brian T. Bateman
Publication year - 2017
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2017.3644
Subject(s) - medicine , methylphenidate , pregnancy , relative risk , medicaid , population , pediatrics , congenital malformations , cohort study , confounding , teratology , stimulant , attention deficit hyperactivity disorder , cohort , obstetrics , confidence interval , psychiatry , fetus , environmental health , health care , genetics , economics , biology , economic growth
Given the rapidly increasing use of stimulant medications during pregnancy and among women of reproductive age who may become pregnant inadvertently, there is a need to better understand their safety.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom